Efficacy of Rifaximin With NAC in IBS-D

Clinical trial NCT06727422 · RECRUITING

Trial details

NCT number: NCT06727422
Sponsor: Mark Pimentel, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

IBS (Irritable Bowel Syndrome)IBS-D (Diarrhea-predominant)

Start date: 2026-02-04
Primary completion: 2026-08-01
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.